Reference number : 236-2016-2017-Q2-00544, amendment number : , agreement type : G, recipient legal name : Campbell, Robert J, recipient country : CA, recipient province : ON, recipient city : Kingston, recipient postal code : K7L 3N6, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 110000.0, agreement start date : 2016-07-01, agreement end date : 2019-06-30, description english : Comparative safety of aflibercept and ranibizumab in the treatment of retinal diseases, description french : Comparative safety of aflibercept and ranibizumab in the treatment of retinal diseases, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2016-17 to 2019-20), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2016-17 à 2019-20), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada